It has only recently become known that two parallel systems of blood formation exist in the body, originating from different ...

Collaboration builds clinical foundation for GNX1021, a first-in-class glycan-directed ADC being developed for gastric cancer patients NEW TAIPEI CITY, Taiwan, Nov. 24, 2025 /PRNewswire/ -- GlycoNex, ...

Innova Therapeutics, a biopharmaceutical company, has announced that it has completed the acquisition of Enci Therapeutics.

PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA ...

Gene Fusion Testing Market to reach USD 2.5 Bn by 2035 at 12.1% CAGR, driven by rising cancer incidence and demand for ...

Clinical updates from ongoing or completed JNJ-1900 (NBTXR3) Phase 1 studies sponsored by Nanobiotix or MD Anderson in melanoma, lung cancer amenable to re-irradiation, pancreatic cancer, and ...

It has only recently become known that two parallel systems of blood formation exist in the body, originating from different precursor cells ...

Q3 2025 Earnings Call Transcript November 24, 2025 BioLineRx Ltd. beats earnings expectations. Reported EPS is $-0.22, ...

Financial foundation toward self-sustained long-term growth established with the closing with HealthCare Royalty ("HCRx") of a non-dilutive royalty financing valued up to $71 millionProgress in the JN ...

Shares of Kymera Therapeutics, Inc. KYMR touched a 52-week high of $68.8 on Nov. 24. The stock is currently trading at $66.04. The rally is most likely due to investor optimism around Kymera’s lead ...

YD Bio Limited ('YD Bio” or the 'Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer ...

UNESCO also invited two legal experts from the Fiji National University, Patricia Chand and Sanjana Datt, to introduce ...